Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse
- PMID: 9399964
- PMCID: PMC508530
- DOI: 10.1172/JCI119872
Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse
Abstract
Intracellular insulin signaling involves a series of alternative and complementary pathways created by the multiple substrates of the insulin receptor (IRS) and the various isoforms of SH2 domain signaling molecules that can interact with these substrates. In this study, we have evaluated the roles of IRS-1 and IRS-2 in signaling to the phosphatidylinositol (PI) 3-kinase pathway in the ob/ob mouse, a model of the insulin resistance of obesity and non-insulin-dependent diabetes mellitus. We find that the levels of expression of both IRS-1 and IRS-2 are decreased approximately 50% in muscle, whereas in liver the decrease is significantly greater for IRS-2 (72%) than for IRS-1 (29%). This results in differential decreases in IRS-1 and IRS-2 phosphorylation, docking of the p85alpha regulatory subunit of PI 3-kinase, and activation of this enzyme in these two insulin target tissues. In ob/ob liver there is also a change in expression of the alternatively spliced isoforms of the regulatory subunits for PI 3-kinase that was detected at the protein and mRNA level. This resulted in a 45% decrease in the p85alpha form of PI 3-kinase, a ninefold increase in the AS53/p55alpha, and a twofold increase in p50alpha isoforms. Thus, there are multiple alterations in the early steps of insulin signaling in the ob/ob mouse, with differential regulation of IRS-1 and IRS-2, various PI 3-kinase regulatory isoforms, and a lack of compensation for the decrease in insulin signaling by any of the known alternative pathways at these levels.
Similar articles
-
Regulation of phosphatidylinositol 3-kinase activity in liver and muscle of animal models of insulin-resistant and insulin-deficient diabetes mellitus.J Clin Invest. 1993 Oct;92(4):1787-94. doi: 10.1172/JCI116768. J Clin Invest. 1993. PMID: 7691886 Free PMC article.
-
Altered expression levels and impaired steps in the pathway to phosphatidylinositol 3-kinase activation via insulin receptor substrates 1 and 2 in Zucker fatty rats.Diabetes. 1998 Jan;47(1):13-23. doi: 10.2337/diab.47.1.13. Diabetes. 1998. PMID: 9421369
-
Regulation of insulin receptor substrate-1 in liver and muscle of animal models of insulin resistance.J Clin Invest. 1992 Nov;90(5):1839-49. doi: 10.1172/JCI116060. J Clin Invest. 1992. PMID: 1331176 Free PMC article.
-
Molecular mechanisms of insulin resistance.Braz J Med Biol Res. 1994 Apr;27(4):941-57. Braz J Med Biol Res. 1994. PMID: 8087096 Review.
-
Molecular mechanisms of insulin resistance: serine phosphorylation of insulin receptor substrate-1 and increased expression of p85alpha: the two sides of a coin.Diabetes. 2006 Aug;55(8):2392-7. doi: 10.2337/db06-0391. Diabetes. 2006. PMID: 16873706 Review.
Cited by
-
Role of Incretins in Muscle Functionality, Metabolism, and Body Composition in Breast Cancer: A Metabolic Approach to Understanding This Pathology.Biomedicines. 2024 Jan 25;12(2):280. doi: 10.3390/biomedicines12020280. Biomedicines. 2024. PMID: 38397883 Free PMC article.
-
Divergent roles of the regulatory subunits of class IA PI3K.Front Endocrinol (Lausanne). 2024 Jan 22;14:1152579. doi: 10.3389/fendo.2023.1152579. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38317714 Free PMC article. Review.
-
Reduced Tyrosine and Serine-632 Phosphorylation of Insulin Receptor Substrate-1 in the Gastrocnemius Muscle of Obese Zucker Rat.Curr Issues Mol Biol. 2022 Nov 29;44(12):6015-6027. doi: 10.3390/cimb44120410. Curr Issues Mol Biol. 2022. PMID: 36547071 Free PMC article.
-
Normalization of maternal adiponectin in obese pregnant mice prevents programming of impaired glucose metabolism in adult offspring.FASEB J. 2022 Jul;36(7):e22383. doi: 10.1096/fj.202200326R. FASEB J. 2022. PMID: 35670755 Free PMC article.
-
LRG1 is an adipokine that mediates obesity-induced hepatosteatosis and insulin resistance.J Clin Invest. 2021 Dec 15;131(24):e148545. doi: 10.1172/JCI148545. J Clin Invest. 2021. PMID: 34730111 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous